Compare TNET & BHC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | TNET | BHC |
|---|---|---|
| Founded | 1988 | N/A |
| Country | United States | Canada |
| Employees | 2700 | N/A |
| Industry | Business Services | Biotechnology: Pharmaceutical Preparations |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.7B | 2.5B |
| IPO Year | 2000 | 1996 |
| Metric | TNET | BHC |
|---|---|---|
| Price | $37.83 | $5.21 |
| Analyst Decision | Hold | Hold |
| Analyst Count | 5 | 3 |
| Target Price | ★ $65.80 | $8.33 |
| AVG Volume (30 Days) | 556.3K | ★ 2.3M |
| Earning Date | 05-15-2026 | 05-18-2026 |
| Dividend Yield | ★ 2.96% | N/A |
| EPS Growth | N/A | ★ 423.08 |
| EPS | ★ 3.20 | 0.42 |
| Revenue | $5,010,000,000.00 | ★ $8,724,000,000.00 |
| Revenue This Year | N/A | $4.48 |
| Revenue Next Year | $3.30 | N/A |
| P/E Ratio | ★ $11.91 | $12.51 |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $33.67 | $4.28 |
| 52 Week High | $88.56 | $8.69 |
| Indicator | TNET | BHC |
|---|---|---|
| Relative Strength Index (RSI) | 39.97 | 36.16 |
| Support Level | $33.67 | N/A |
| Resistance Level | $39.10 | $7.22 |
| Average True Range (ATR) | 1.74 | 0.19 |
| MACD | 0.81 | -0.04 |
| Stochastic Oscillator | 70.31 | 24.03 |
Trinet Group Inc provides human resources solutions for small and medium-sized businesses through technology-enabled services. Its offerings include human capital expertise, employee benefits such as health insurance and retirement plans, payroll and payroll tax administration, risk mitigation, and compliance consulting. The company provides its services through professional employer organization (PEO) services delivered via a co-employment model, as well as administrative services organization (ASO) offerings. The majority of the company's revenue is derived from the insurance-related billings and administrative fees collected from PEO clients.
Bausch Health Companies Inc is a world-wide specialty pharmaceutical, consumer health, and medical device company with a focus on branded products for the gastroenterology, hepatology, neurology and dermatology markets. The company reports revenue in five segments: Salix; International; Solta Medical; Diversified Products and Bausch + Lomb. It generates maximum revenue from the Bausch + Lomb segment.